← All trials
NCT03790033
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 11, 2018
- Primary completion
- Dec 31, 2019
- Completion date
- May 14, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 164
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Gachon UniversityLead sponsor
- Gachon UniversityReponsible party - principal investigator
- Kyung Hee UniversityCollaborator
- Sangji UniversityCollaborator
- Semyung UniversityCollaborator
- Gachon UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.